: CVS, other pharmacy-benefit stocks drop as major health insurer targets ‘broken’ prescription-drug system

Pressure builds on prescription-drug middlemen as Blue Shield of California cuts reliance on CVS Caremark.

Previous post Earnings Results: Coach parent Tapestry’s earnings and guidance fall short of consensus, pressuring the stock
Next post : Gold futures post a 9th straight session decline